{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:28:14Z","timestamp":1793381294446,"version":"4.5.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"34","license":[{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8,23]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Gitelman syndrome (GS) is a rare autosomal recessive inherited salt-losing tubulopathy, typically devoid of hypercalcemia. Herein, we described one patient of GS presenting with hypercalcemia concomitant with primary hyperparathyroidism (PHPT).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>On September 28, 2020, a middle-aged female patient was admitted to our hospital with a 12-year history of hypokalemia and hypomagnesemia. Laboratory examinations unveiled hypokalemia with renal potassium wasting, hypomagnesemia, metabolic alkalosis, hypocalciuria, and gene sequencing revealed a homozygous mutation in <jats:italic toggle=\"yes\">SLC12A3<\/jats:italic> (c.179C\u2005&gt;\u2005T [p.T60M]). Subsequently, the diagnosis of GS was confirmed. In addition, the patient exhibited hypercalcemia and elevated levels of parathyroid hormone. Parathyroid ultrasound revealed left parathyroid hyperplasia, consistent with PHPT. Following aggressive treatment with potassium chloride and magnesium oxide, her serum potassium rose to 3.23 mmol\/L, serum magnesium was 0.29 mmol\/L, and her joint pain was relieved.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Based on the patient\u2019s medical history, laboratory findings, and gene sequencing results, the definitive diagnosis was GS concomitant with PHPT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>PHPT should be taken into consideration when patients diagnosed with GS exhibit hypercalcemia. While the serum potassium level readily exceeded the target threshold, correcting hypomagnesemia proved challenging, primarily because PHPT augments urinary magnesium excretion.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000039447","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T05:02:11Z","timestamp":1724648531000},"page":"e39447","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Gitelman syndrome with primary hyperparathyroidism: A case report"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3714-9370","authenticated-orcid":false,"given":"Shanshen","family":"Yu","sequence":"first","affiliation":[{"name":"Linping Campus, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Sun","sequence":"additional","affiliation":[{"name":"Linping Campus, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Mou","sequence":"additional","affiliation":[{"name":"Division of Nephrology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11255-017-1653-4","article-title":"Gitelman syndrome: an analysis of the underlying pathophysiologic mechanisms of acid-base and electrolyte abnormalities.","volume":"50","author":"Filippatos","year":"2018","journal-title":"Int Urol Nephrol"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.kint.2016.09.046","article-title":"Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.","volume":"91","author":"Blanchard","year":"2017","journal-title":"Kidney Int"},{"key":"R3-20250503","first-page":"224","article-title":"Evidence for disturbed regulation of calciotropic hormone metabolism in Gitelman syndrome.","volume":"80","author":"Bianchetti","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1365-2265.2002.01223.x","article-title":"Severe hypomagnesaemia-induced hypocalcaemia in a patient with Gitelman\u2019s syndrome.","volume":"56","author":"Pantanetti","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2265.1976.tb01947.x","article-title":"Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency.","volume":"5","author":"Rude","year":"1976","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1172\/JCI107159","article-title":"Pathogenesis of hypocalcemia in primary hypomagnesemia: normal end-organ responsiveness to parathyroid hormone, impaired parathyroid gland function.","volume":"52","author":"Suh","year":"1973","journal-title":"J Clin Invest"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1210\/jcem-73-5-1067","article-title":"Effect of experimental human magnesium depletion on parathyroid hormone secretion and 1,25-dihydroxyvitamin D metabolism.","volume":"73","author":"Fatemi","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1634\/theoncologist.2014-0084","article-title":"Mild primary hyperparathyroidism: a literature review.","volume":"19","author":"Applewhite","year":"2014","journal-title":"Oncologist"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3390\/genes12030369","article-title":"Simultaneous Homozygous Mutations in SLC12A3 and CLCNKB in an Inbred Chinese Pedigree.","volume":"12","author":"Mou","year":"2021","journal-title":"Genes"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/cge.13913","article-title":"Multi-centre study of the clinical features and gene variant spectrum of Gitelman syndrome in Chinese children.","volume":"99","author":"Shen","year":"2021","journal-title":"Clin Genet"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s40618-018-0966-1","article-title":"Characteristics and follow-up of 13 pedigrees with Gitelman syndrome.","volume":"42","author":"Zhong","year":"2019","journal-title":"J Endocrinol Invest"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12902-021-00838-y","article-title":"Association between hypomagnesemia and severity of primary hyperparathyroidism: a retrospective study.","volume":"21","author":"Na","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.suc.2019.04.006","article-title":"Diagnosis and evaluation of primary hyperparathyroidism.","volume":"99","author":"Machado","year":"2019","journal-title":"Surg Clin North Am"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/bmj.1.5695.529","article-title":"Plasma magnesium concentration in primary hyperparathyroidism.","volume":"1","author":"Sutton","year":"1970","journal-title":"Br Med J"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/0026-0495(84)90067-2","article-title":"Renal and systemic magnesium metabolism during chronic continuous PTH infusion in normal subjects.","volume":"33","author":"Hulter","year":"1984","journal-title":"Metabolism"},{"key":"R16-20250503","first-page":"e3840","article-title":"Updated treatment for calcium pyrophosphate deposition disease: an insight.","volume":"11","author":"Iqbal","year":"2019","journal-title":"Cureus"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-2003-43228","article-title":"Calcium pyrophosphate dihydrate crystal deposition disease.","volume":"7","author":"Bencardino","year":"2003","journal-title":"Semin Musculoskelet Radiol"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/OARRR.S39039","article-title":"Calcium pyrophosphate crystal deposition disease: diagnosis and treatment.","volume":"6","author":"Rosales-Alexander","year":"2014","journal-title":"Open Access Rheumatol"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"101718","DOI":"10.1016\/j.berh.2021.101718","article-title":"Pathogenesis of calcium pyrophosphate deposition disease.","volume":"35","author":"Williams","year":"2021","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5152\/eurjrheum.2017.16116","article-title":"Magnesium disorders can cause calcium pyrophosphate deposition disease: a case report and literature review.","volume":"5","author":"Joshi","year":"2018","journal-title":"Eur J Rheumatol"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1148\/radiology.178.3.1994435","article-title":"Deposition of calcium pyrophosphate dihydrate crystals in the ligamentum flavum: evaluation with MR imaging and CT.","volume":"178","author":"Brown","year":"1991","journal-title":"Radiology"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00003086-199304000-00016","article-title":"Lumbar spinal stenosis secondary to calcium pyrophosphate crystal deposition (pseudogout).","volume":"289","author":"Delamarter","year":"1993","journal-title":"Clin Orthop Relat Res"},{"key":"R23-20250503","first-page":"955","article-title":"Calcium pyrophosphate dihydrate deposition in lumbar disc fibrocartilage.","volume":"8","author":"Ellman","year":"1981","journal-title":"J Rheumatol"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.rdc.2014.01.002","article-title":"Epidemiology of calcium pyrophosphate crystal arthritis and basic calcium phosphate crystal arthropathy.","volume":"40","author":"Abhishek","year":"2014","journal-title":"Rheum Dis Clin North Am"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/ckj\/sfab034","article-title":"Gitelman syndrome and ectopic calcification in the retina and joints.","volume":"14","author":"Ham","year":"2021","journal-title":"Clin Kidney J"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1093\/rheumatology\/keab578","article-title":"Calcium pyrophosphate crystal deposition in a cohort of 57 patients with Gitelman syndrome.","volume":"61","author":"Chotard","year":"2021","journal-title":"Rheumatology"},{"key":"R27-20250503","first-page":"460","article-title":"Calcium pyrophosphate crystal deposition disease and hyperparathyroidism: a controlled, prospective study.","volume":"5","author":"Rynes","year":"1978","journal-title":"J Rheumatol"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3109\/03009748409102668","article-title":"Chondrocalcinosis in primary hyperparathyroidism. Influence of parathyroid activity and age.","volume":"13","author":"McGill","year":"1984","journal-title":"Scand J Rheumatol"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1507\/endocrj1954.38.457","article-title":"Prevalence of chondrocalcinosis in patients with primary hyperparathyroidism in Japan.","volume":"38","author":"Yashiro","year":"1991","journal-title":"Endocrinol Jpn"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/acr.23160","article-title":"Calcium pyrophosphate deposition disease and associated medical comorbidities: a national cross-sectional study of US Veterans.","volume":"69","author":"Kleiber Balderrama","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/ard.2010.139105","article-title":"European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis.","volume":"70","author":"Zhang","year":"2011","journal-title":"Ann Rheum Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039447","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:04:48Z","timestamp":1746317088000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,23]]},"references-count":31,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000039447","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,23]]}}}